1. American Psychiatric Association (1987).Diagnostic and Statistical Manual of Mental Disorders (3rd ed. ?rev. ed.), APA, Washington, DC.
2. Archer, T. (1989). Neurotoxin-induced cognitive and motor activity modifications: A catecholamine connection. In Sagvolden, T., and Archer, T. (eds.),Attention Deficit Disorder: Clinical and Basic Research, Lawrence Erlbaum Associates, Hillsdale, NJ; pp. 287?322.
3. Bianchi, G., Ferrari, P., and Barber, B. R. (1990). Lessons from experimental genetic hypertension. In Laragh, J. H., and Brenner, B. M. (eds.),Hypertension: Pathophysiology, Diagnosis and Management, Raven, New York.
4. Biederman, J., Faraone, S. V., Keenan, K., Knee, D., and Tsuang, M. T. (1990). Family-genetic and psychosocial risk factors in DSM-III Attention Deficit Disorder.J. Am. Acad. Child Adoles. Psychiat. 29:526?532.
5. Bindra, D., and Anchel, H. (1963). Immobility as an avoidance response, and its disruption by drugs.J. Exp. Anal. Behav. 6:213?218.